Nikolaus McFarland

Skip to main content All experts

CLIN PROF

MD-NEUROLOGY

Orcid identifier0000-0002-8699-8857 (opens in a new tab)⁠

CLIN PROF
MD-NEUROLOGY

nikolaus.mcfarland@neurology.ufl.edu (opens in a new tab)

sort by:

GRANT
1Florida Alzheimer's Disease Research Center Years 6-10
National Institute of Health Nia4 Sep 2026 - 30 Jun 2031
Active
GRANT
A randomized, placebo-controlled, double-blind Phase 3 study to evaluate the efficacy, safety and tolerability of votoplam in participants with Huntington’s Disease
Novartis Pharmaceuticals Corporation1 Jul 2026 - 30 Mar 2032
Active
GRANT
CUREPSP CoC 2026-2027
Cure Psp Foundation23 Jun 2026 - 30 Jun 2027
Active
GRANT
A Phase 2, Randomized, Double-Blind, Sham Surgery-controlled Study of the Efficacy and Safety of Intraputaminal AAV2-GDNF in the Treatment of Adults with Moderate Stage Parkinson’s Disease
Askbio Inc14 May 2026 - 13 May 2031
Active
GRANT
2026 UF MSA Center of Excellence
Multiple System Atrophy Coalition27 Feb 2026 - 31 Dec 2027
Active
GRANT
HDSA 2025 extension on PRO00064796/AWD18562
Huntingtons Disease Society of America20 Feb 2026 - 31 Dec 2026
Active
GRANT
Phase 2/3 Randomized, Double- Blind, Placebo Controlled Study of BHV-8000 in Participants with Early Perkinson’s Disease (“Protocol”).
Biohaven Pharmaceuticals3 Nov 2025 - 18 Sep 2026
Expired
GRANT
CurePSP Centers of Care 2025-2026
Cure Psp Foundation3 Jul 2025 - 30 Jun 2026
Expired
GRANT
HDSA Center of Excellence 2025: University of Florida, Fixel Institute for Neurological Diseases
Huntingtons Disease Society of America7 May 2025 - 31 Dec 2025
Expired
GRANT
Interventional, randomized, double-blind, placebo-controlled, optional open-label extension trial of Lu AF82422 in participants with Multiple System Atrophy”, number: 20432A
H. Lundbeck A/S4 Mar 2025 - 3 Mar 2030
Active
GRANT
UF MSA Center of Excellence
Multiple System Atrophy Coalition27 Jan 2025 - 31 Dec 2025
Expired
GRANT
The Parkinson’s Progression Markers Initiative (PPMI) Clinical - Establishing a Deeply Phenotyped PD Cohort
Fox Foundation, Michael J14 Oct 2024 - 14 Apr 2025
Expired
GRANT
Pridopidine Post Trial Access Protocol in Patients with Huntington's Disease. (“PTAP”)
Prilenia Therapeutics11 Sep 2024 - 10 Sep 2029
Active
GRANT
A35-009, A Phase 2b/3 Study of Safety and Efficacy of AMX0035 in Progressive Supranuclear Palsy (ORION)
Amylyx Pharmaceuticals16 Jul 2024 - 22 Oct 2025
Closed
GRANT
Deep Learning Methods for Improving Gallium 68-Based PET Imaging####
National Institute of Health Nibib11 Jul 2024 - 30 Apr 2028
Active
GRANT
CurePSP Centers of Care 2024-2025
Cure Psp Foundation1 Jul 2024 - 30 Jun 2025
Expired
GRANT
HDSA Center of Excellence 2024: University of Florida, Fixel Institute for Neurological Diseases
Huntingtons Disease Society of America20 Feb 2024 - 31 Dec 2024
Expired
GRANT
A Phase 2, double-blind, placebo-controlled, parallel-group study to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and potential efficacy of multiple doses of ONO-2808 in patients with Multiple System Atrophy (MSA)
Ono Pharmaceutical24 Jan 2024 - 23 Jan 2029
Active
GRANT
UF MSA Center of Excellence
Multiple System Atrophy Coalition6 Nov 2023 - 5 Nov 2024
Expired
GRANT
FY24 CurePSP Center of Care Award
Cure Psp Foundation27 Jun 2023 - 30 Jun 2024
Expired
GRANT
A Randomized, Double-blind, Placebo-controlled Study of ATH434 in Multiple System Atrophy
Alterity Therapeutics1 Jun 2023 - 16 Apr 2024
Closed
GRANT
HDSA Center of Excellence 2023 Award: University of Florida
Huntingtons Disease Society of America23 Feb 2023 - 31 Dec 2023
Expired
GRANT
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen in Individuals with Prodromal and Early Manifest Huntington's Disease
Genentech Inc22 Feb 2023 - 7 Feb 2028
Active
GRANT
214 Fund - CTOA McFarland CT Salary
University of Florida25 May 2022 - 24 May 2027
Active
GRANT
Cure PSP Center of Care
Cure Psp Foundation16 May 2022 - 31 Mar 2023
Expired

GRANTS